MRI Assessment of Nigrosome in Parkinson's Disease: Is it Currently a Valuable Tool in Clinical Practice?
Movement Disorders Clinical Practice · 2026-06 · 13 (6) · 1508-1512
DOI: 10.1002/mdc3.70530 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders Clinical Practice, online erschienen am 19.01.2026. Verfasst von Agustina Ruiz Yanzi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centro Integral de Neurociencias AC (CINAC), HM Universitario Puerta del Sur, Madrid, Spain. Hauptthemen laut MEDLINE: Parkinson Disease, Magnetic Resonance Imaging, Substantia Nigra, Essential Tremor. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Dopaminergic neuron loss in the substantia nigra, particularly the nigrosomes, characterizes Parkinson's disease (PD). Nigrosome‐1 absence on MRI has emerged as a potential PD biomarker.
Objectives
Assess the diagnostic accuracy of nigrosome‐1 detection for differentiating PD from essential tremor (ET) in clinical practice.
Methods
Movement disorder neurologists without nigrosome evaluation experience, randomized into receiving or not training, assessed 3 Tesla MRIs from PD and ET patients. PD was defined by absence of at least one nigrosome. Diagnostic accuracy measures and inter‐rater agreement were calculated.
Results
Seventy‐two MRIs were included (43 PD, 29 ET). Mean sensitivity, specificity, and accuracy were 78.2% (95% confidence interval: 71.2–85.3), 56.7% (50.0–64.0), 69.5% (65.3–73.9), without significant differences between groups. Specificity ( P = 0.002) and accuracy ( P = 0.029) increased with rating experience.
Conclusions
Nigrosome assessment in routine MRI by inexperienced raters showed limited diagnostic performance, yet may improve with optimized protocols and continued practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centro Integral de Neurociencias AC (CINAC), HM Universitario Puerta del Sur, Madrid, Spain.
- Instituto de Investigación Sanitaria HM Hospitales, Madrid, Spain.
- PhD Neurosciences Program, Universidad Autónoma de Madrid, Madrid, Spain.
- PhD Medicine Program, Universidad Autónoma de Madrid, Madrid, Spain.
- CIBERNED, Instituto de Salud Carlos III, Madrid, Spain.
ORCID-Profile: Elena Natera-Villalba, Michele Matarazzo
Zitieren
APA
Ruiz Yanzi, A., Pineda-Pardo, J. Á., Natera-Villalba, E., Obeso, J. A., & Matarazzo, M. (2026). MRI Assessment of Nigrosome in Parkinson's Disease: Is it Currently a Valuable Tool in Clinical Practice?. Movement Disorders Clinical Practice, 13(6), 1508-1512. https://doi.org/10.1002/mdc3.70530
Vancouver
Ruiz Yanzi A, Pineda-Pardo JÁ, Natera-Villalba E, Obeso JA, Matarazzo M. MRI Assessment of Nigrosome in Parkinson's Disease: Is it Currently a Valuable Tool in Clinical Practice?. Movement Disorders Clinical Practice. 2026;13(6):1508-1512. doi:10.1002/mdc3.70530
BibTeX
@article{RuizYanzi2026,
author = {Ruiz Yanzi, Agustina and Pineda-Pardo, José Á and Natera-Villalba, Elena and Obeso, José A and Matarazzo, Michele},
title = {MRI Assessment of Nigrosome in Parkinson's Disease: Is it Currently a Valuable Tool in Clinical Practice?},
journal = {Movement Disorders Clinical Practice},
year = {2026},
volume = {13},
number = {6},
pages = {1508--1512},
doi = {10.1002/mdc3.70530}
}
EUVIMED